Manufacturers receiving FDA orders to track a device, whose failure would likely have serious adverse health consequences, and which is implanted in humans for more than 1 year, or is life-sustaining or life-supporting and used outside a device user facility, are required to collect/maintain current tracking information about the identity and location of the device during distribution, and about the identity and location of patients receiving the device, including certain physician information. Distributors must report this data to manufacturers.
The burden hours and responses have been adjusted as the result of re-estimating and re-evaluating submissions and tracking data by the agency. FDA attributes the reduction to the decreased number of tracking orders issued since original estimates were provided. More specifically, while the Safe Medical Devices Act of 1990 required tracking by all manufacturers of certain devices, FDAMA (enacted in 1997) provides that devices subject to tracking would be determined at the Agency's discretion and only upon order by FDA.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.